BEIJING, July 7 Lotus Pharmaceuticals, Inc.(OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a growing developer,manufacturer and seller of medicine and drugs in the People's Republic ofChina (the "PRC"), today announced it will present at the Global HunterSecurities 2010 China Conference held July 11-13, 2010 in San Francisco,California. Presentation details are noted below.
Lotus will also be available for one-on-one meetings with investors on the12th and 13th. Investors interested in attending the event should contactGlobal Hunter Securities. For more information about the conference, pleasevisit http://www.ghsecurities.com/ .
About Lotus Pharmaceuticals, Inc. ( http://www.lotuspharma.com )
Lotus Pharmaceuticals, Inc. is a growing developer and producer of drugsand a licensed national seller of pharmaceutical items in the PRC. Lotusoperates its business through its two controlled entities: Liang FangPharmaceutical, Ltd. and En Ze Jia Shi Pharmaceutical, Ltd. Lotus' currentdrug development is focused on the treatment of cerebro-cardiovascular disease,asthma, and diabetes. Liang Fang sells drugs directly and indirectly throughits national sales channels to hospitals, clinics and drugs stores in 30provinces of the PRC.Date: Monday, July 12, 2010 Time: 3:30 PM Location: The St. Regis Hotel, San Francisco, CA
SOURCE Lotus Pharmaceuticals, Inc.